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Introduction
Although significant advances have been made in preventing and treating cancer, of which the mortality rate of remains to be unacceptably high. Meanwhile, many of the current chemotherapeutics are limited by significant side effects, unpredictable efficacies and/or acquired resistances [1] [2] [3] .
Human hepatocellular carcinoma (HCC) and colorectal carcinoma are most common types of malignancy in sub-Saharan Africa and Southeast Asia like Taiwan and China. It is also the fifth most common and lethal cancer worldwide. Most of all, HCC is the most frequent malignant tumor and Figure 1. Chemical structures of berberine (1) and berberrubine (2) .
In addition, recent study reported various analogs of berberine on 9-/13-position using different chain lengths and terminal amino groups were synthesized and evaluated on it the DNA-binding affinity or as G-quadruples stabilizing ligands [23] [24] [25] [26] . Study have also showed that the introduction of a lipophilic substituent into 9-O-position of berberine backbone enhance the anti-proliferative activities against human cancer cell lines (HepG2 and HT-29) [27] . However, structural modification on the 13-position of berberine backbone has rarely been reported [28] . To explore its intestinal absorption and inhibitory function, in this study we modified berberine analogues and evaluated its photo-induced cytotoxicity in vitro on human liver HepG2, bladder BFTC905 and colon HT29 cancer cell lines. The type of functional groups, n-alkyl derivatives of berberine at 9-or 13-position was investigated for the structure-activity relationship (SAR).
Results and Discussion

Chemistry
In general, the desired berberine derivatives are synthesized with long chain n-alkyl bromide through 9-/13-alkylation. As shown in Scheme 1, in specific, synthesis of 5a-e, 6a-e and 7a-e was berberine derivatives were tested against three human cancer cell lines and one normal murine embryonic liver cell line. The cancer cells under study were HepG2 (liver carcinoma), HT29 (colon carcinoma), and BFTC905 (bladder carcinoma). As shown in Table 1 , we found firstly, as a trend, the anticancer activity of these compounds increases with the alkyl chain length, or lipophilic characteristics, of the substitutes. Thus, the remarkable anticancer activity of the berberine derivatives with 9-/13-position substitution of the dodecyl moiety can be attributed to their enhanced bioavailability and cell membrane permeability through the increased lipophilicity. As it was shown in Fig. 2 , that the lipophilicity effect of three bioactive derivatives; compounds 5e (9-O-dodecylberberine), 6e (13-dodecylberberine) and 7e (13-O-decylberberine) . In essence, all shows significant cell growth inhibition with the IC50 values of 0.32 ± 0.08, 0.77 ± 0.18 and 0.83 ± 0.30 μM, respectively, against human liver carcinoma HepG2 cells. Compared to berberine (1)'s IC50 value of >40 μM, these three derivatives evince 48-to 125-fold stronger cytotoxicity potency. In other words, through a simple structure-activity relationship (SAR) analysis we have shown that the cell growth inhibitory potency closely related to the chain length of n-alkyl groups. Meanwhile, to check potential side effect, we treated normal Madin-Darby Canine Kidney (MDCK) cell lines with berberine (1) and compounds 5e, yet detected no significant cell death (data not shown). Furthermore, only a marked effect on cell death (under 20%) was observed at the maximum concentration (4 μM) of 5e and 6e after 48 h treatment, except for berberine (1) which exhibited slight toxic. It appeared that compounds 5e, 6e and 7e are cytotoxic to human colon cancer cells with no significant adverse effects on normal MDCK cells. Table 1 . Cytotoxicity of berberine and its derivatives against three human cancer cell lines for 24 h. a Calculated log value of partition coefficient by ChemDraw Ultra 11.0. b Compound concentration (μM) required to inhibit tumor cell proliferation rate by 50 %. Data are expressed as the mean ± SD from the dose response curves of at 3-5independent experiments. c Human hepatocarcinoma cell lines. d Human bladder cancer cell lines. e Human colon adenocarcinoma cell lines.
To confirm the findings above, we calculated partition coefficients (clogP) values of 9-/13-substituted berberine derivatives and compared it with the cytotoxic activity. As shown in Table 1 , clogP values correlate well with tested anticancer activity for 9-/13-substituted berberine derivatives. These results just once again verify that the lipophilicity or the chain length of the n-alkyl moieties of 9-/13-substituted berberine derivatives plays a very important role on their anticancer activity.
Further the positive clogP values of berberine derivatives 5e, 6e and 7e showed that the introduction of long chain n-alkyl groups to the berberine scaffold at the 9-O-, 13-and 13-O-position will moderately augment the lipophilicity of berberine, while n-alkyl substituents at the 9-O-, 13and 13-O-positions of berberine remarkably increase the lipophilicity of berberine (Table 1) . It worth noting also, berberine derivatives with moderate carbon chain length (5e, 6e and 7e) would significantly enhance its lipophilicity, and yield much more favorable transmembrane permeability. In general, clogP value is a good index in estimating the distribution of drugs within the cells. Thus, hydrophobic drugs with high 1-octanol/water partition coefficients are preferentially distributed to hydrophobic compartments such as the lipid bilayers of cells while hydrophilic drugs (low 1-octanol/water partition coefficients) preferentially are found in aqueous compartments such as blood serum.
Absorption and emission spectra of berberine (1) and its derivatives (5e, 6e and 7e)
The absorption and fluorescence spectra of berberine (1) and its derivatives (5e, 6e and 7e) in MeOH were measured (Fig. 3) . The absorption spectrum of the derivative 6e, with dodecyl group at 13-position of berberine, exhibited a moderate bathochromic shift (ca. 8.3 nm) than other compounds. Its absorptivity was obviously significantly decreased compared with that of berberine (1) and other derivatives. Fig. 3B showed the emission spectra of berberine (1) and its derivatives (5e, 6e and 7e) in MeOH (10 μM). All gave the excitation wavelength at 420 nm with the emission maxima of 529, 531, 516, and 524 nm, respectively. The data suggested that compounds 6e and 7e have higher energy of the emission spectra in MeOH, which, in turn, may enhance its photocytotoxicity in photodynamic therapy. 
Intracellular uptake of berberine (1) and its derivatives (5e, 6e and 7e)
Intracellular uptake of an anticancer agent is to check if the medicine would be able to target key organelles of the cell. Using time-dependent HPLC analysis we studied the cellular uptake of berberine (1) and it derivatives. First cells were treated with 10 µM of berberine (1) and its derivatives at different time points, viz. 0.25, 1, 2, 4 and 8 h. The emission of the berberine (1) and its derivatives inside the cells was monitored (Fig. 4 ). The percentage incorporation of berberine (1) and it derivatives (5e, 6e and 7e) into the cells is shown in the figure 4. The data suggested that both the berberine (1) and it derivatives internalize into the cancer cells to the same extent with similar rates of internalization. A nearly 100% uptake was observed when the cells were incubated with the compounds for 2-4 h. As shown in Fig. 4 , we found that the intracellular concentrations of berberine (1) and its three derivatives increased rapidly in 1 h, reached a plateau at 2 h, then stay at the plateau for another 6 h. The uptake amounts of compounds 5e, 6e and 7e are significantly higher than that of berberine (1). This observation confirmed our calculated higher partition coefficients (clogP) of compounds 5e, 6 e and 7e. in HepG2 cells. HepG2 cells (1× 10 6 ) were treated with 10 μM of berberine and its derivatives (5e, 6e and 7e) and then incubated for 0 h, 0.25 h, 1 h, 2 h, 4 h or 8 h.
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Intracellular concentrations of berberine (1) and its derivatives (5e, 6e and 7e) were detected using HPLC analysis. Data are shown as the mean ± SD (n = 3) of two independent experiments.
Photocytotoxicity of berberine (1) and its derivatives (5e, 6e and 7e)
To determine the photo-induced cytotoxicity of berberine (1) and it derivatives (5e, 6e and 7e)
in HepG2 cells, proliferation assay was performed. Exponentially growing HepG2 cells were exposed for 10 min to visible light (420 nm, 5.9 mW/cm 2 ) in presence of increasing concentrations of berberine (1) and its derivatives. Subsequently, the effect of the treatments on cell proliferation was determined by cell counts right after damage and after 20 h of incubation in fresh media, free of berberine derivatives. It is notable that, as shown in Fig In light of the dark cytotoxicity findings described above, we extended our study further on the anti-proliferation efficacy of berberine (1), compounds 5e, 6e and 7e against HepG2 cells over a 24 h period with data on berberine (1) as the base case. As shown in Table 2 , first of all, the dark cytotoxicity of compounds 5e, 6e and 7e demonstrate, once again, an impressive 125-, 52-and 48-fold, respectively, stronger bioactivity than that of berberine (1) in vitro. In addition, the growth inhibition of HepG2 cells induced by these three samples is a concentration-and light dose-dependent manner. Further, the photo-induced cytotoxic effects of berberine (1) and its derivatives on three human cancer cell lines was assessed using a light dose of 3.36 J/cm 2 at 420 nm wavelength, respectively. The resulting cells were irradiated with visible light (420 nm) for 10 min irradiation.
After photo-irradiation, the cell viability was measured by MTT assay, of which these results are shown in Fig. 5 along with IC50 values in Table 2 . The control experiment without light irradiation showed slight cytotoxicity (85 ~ 95% of the cell viability). The dark cytotoxicity of these berberine derivatives was evaluated in HepG2 cells at the concentration of 0.5 μM without photo-irradiation.
We found that all berberine derivatives showed no significantly cytotoxicity in the dark ( Fig. 5 ), except over 1 μM. Furthermore, Fig. 5 showed the cell survival ratio as a function of the concentrations of berberine derivatives. The IC50 value of 6e was 0.15 μM which was almost the same as that of 7e (0.14 μM) and lower than that of 5e (0.28 μM). Human hepatocarcinoma cell lines. c Human bladder cancer cell lines. d Human colon adenocarcinoma cell lines.
Cell morphological assessment
The apoptotic cells change in morphology, such as chromatin condensation, nuclear shrinking and DNA fragmentation. It can be characterized through Hoechst 33258 stained cell nucleus [30] under a fluorescent microscope. Thus, to further study the role of apoptosis played in the superior cytotoxicity of compounds 5e, 6e and 7e, we incubated HepG2 cells in 0.5 μM of berberine (1), or its three derivatives separately. As shown in Fig. 6A , while the nuclei of the cells were round in shape and stained homogenously in the control without testing compound, those treated with berberine
(1), compound 5e, 6e or 7e showed typical morphological features of apoptosis such as nuclear shrinkage, chromatin condensation and DNA fragmentation [30] . 
Cell cycle distribution analysis using flow cytometry
To probe the apoptotic effects of berberine (1) and its derivatives on cell cycle progression of HepG2 cells were treated once again with these compounds, separately, at 0.5 μM concentrations for 2 h after irradiation (420 nm, 10 min) for 24 h. Then the samples were further treated with propidium iodide (PI) staining [31] and of which the sub-G1 phase was analyzed by flow cytometry. Besides, the cells with no test compound were the control of the experiment. Berberine (1) and its derivatives (5e, 6e and 7e) showed significant photocytotoxic property in visible light at 420 nm wavelength. To find out whether the said property play a role in the apoptosis of the cells, flow cytometric analysis of the HepG2 cells treated with berberine (1) and its derivatives (5e, 6e and 7e) was carried out at 0.5 μM concentrations. Cells initially treated with the compounds in the dark and tested before and after being exposed to visible light (420 nm), and then stained with propidium iodide (PI) to observe any fragmented DNA, or an increase in the sub-G1 population. As illustrated in Fig. 7 , the percentage of S phase increases by 32.71% and 37.58% in dark and light for the control, respectively, in sample with of 5e increase to 41.14%, 49.71% for 6e and 44.36% for 7e compare to the 37.58% for the control in the light. The increased S phase percentage and the sub-G1 population in compounds 5e, 6e and 7e treatment suggest that 5e, 6e and 7e induce S phase arrest and cause apoptosis in 
Measurement of intracellular ROS production by irradiation
Measurements of mitochondrial membrane potential changes
The depletion of mitochondrial membrane potential (MMP) is an early marker of the apoptotic process. To determine whether an early loss of MMP occurred upon the treatment of berberine (1) and its derivatives in HepG2 cells, we performed MMP measurement with rhodamine 123 staining.
Delineated in Fig. 9 , the MMP decreased remarkably at the concentrations of 0.5 μM of berberine (1), 0.25 μM of compound 5e, 6e or 7e. The percentage of cells with membrane potential loss increased from 20.53% to 32.90% at 24 h. Thus berberine (1), compound 5e, 6e or 7e severely damaged the DNA of HepG2 cells. It was documented that P53 could also down-regulate Bcl-2 and up-regulate Bax, which are related to mitochondria mediated apoptosis [33] . Further, several studies have also reported that apoptosis involves a disruption of the mitochondrial membrane integrity, a critical cell death process. Moreover, depolarization of the mitochondrial membrane potential is a characteristic feature of apoptosis [34, 35] . Report also indicated that the reduction of the membrane potential, the release of mitochondrial cytochrome c, a critical step, is followed by the formation of apoptosomes [35] . Thus what we found the loss of MMP upon the treatments of berberine (1), compound 5e, 6e or 
Materials and Methods
General information
All chemical reagents and solvents in commercial quality were purchased from Sigma-Aldrich 
Synthesis of 9-O-sunstituted berberine derivatives (5a-e)
To a solution of berberrubine 2 (1 mmol) in dry acetonitrile (10 mL) was added various n-alkyl bromide (1.2 mmol) and the reaction mixture was refluxed for 4-8 hours. The progress of the reaction was monitored by TLC. Then, the reaction mixture was cooled to room temperature and the solvent was removed under reduced pressure. The crude product was chromatographed on a silica gel column and eluted with ethyl acetate/methanol (2/1) solvent to afford the desired berberine derivatives 5a-e. 
9-O-Butylberberine bromide (5a
Synthesis of 13-sunstituted berberine derivatives (6a-e)
To a stirred solution of berberine (1) (3.71 g, 10 mmol) and K2CO3 (3.6 g, 30 mmol) in methanol (125 mL), 5% NaOH (5 mL) solution containing NaBH4 (0.30 g, 7.5 mmol) was added dropwise. The reaction mixture was stirred at room temperature for 1 h and the precipitated product was filtered, washed with 30% ethanol (20 mL) and 80% ethanol (20 mL), and then recrystallized from absolute ethanol to provide dihydroberberine (3) To a stirred solution of dihydroberberine (3) (170 mg, 5.0 mmol) in 80% ethanol (8 mL) and
HOAc (2 mL), n-alkyl aldehyde (2 mL) was added. The reaction mixture was heated to 85-95 °C for 5 h. The solvent was removed by evaporation, and the residue was acidified by 2 N HCl (5 mL), and then stirred at room temperature for 1 h. The solid was collected by filtration and then purified by flash chromatography over silica gel, affording the title compounds 6a-e. (3) 
13-Butylberberine bromide (6a). Dihydroberberine
Synthesis of 13-O-sunstituted berberine derivatives (7a-e)
Compound 3 (337 mg) was dissolved in 35 mL of CH2Cl2. Under nitrogen atmosphere, the temperature of the system was kept at -25°C ~ -30°C, and 8 mL of CH2Cl2 solution containing 258 mg MCPBA (1.5 mmol) was dropwise added slowly. After the addition, the temperature was kept and the reaction was carried out under agitation for 1 h. Then, the temperature was raised to 0 °C and 250 mg (2.0 mmol) of sodium sulfite was added therein, followed by stirred at room temperature for 1 h. The reaction was stopped and the reaction mixture was filtered. The filtrate was evaporated to remove the solvent under reduced pressure and the residue was purified through silica gel column chromatography (CH2Cl2/CH3OH = 10 : 1) to obtain compound 4 (280 mg, Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 9 January 2020 doi:10.20944/preprints202001.0081.v1
Compound 4 (1.0 g) and potassium carbonate (200 mg) were dissolved in 20 mL of acetone followed by adding 0.25 mL of alkyl bromide. The obtained reaction solution was heated and refluxed for 3 hours. Then, the reaction mixture was filtered and the filtrate was evaporated under reduced pressure. The residual was purified through silica gel column (CH2Cl2/CH3OH = 20: 1) to obtain compounds 7a-e. incubator, Osaka, Japan).
13-O-
Cell viability inhibition assay
Cell viability was assessed by staining with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, Bionovas Biotechnology Co., Ltd., Toronto, Ontario, Canada) [29] .
Cancer cells were plated at 5 ×10 3 - Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 9 January 2020 doi:10.20944/preprints202001.0081.v1
Cell viability was determined the test compound concentration required to inhibit tumor cell proliferation by 50% (IC50) from the dose-response curves. All data average values from triplicate samples and the experiments were repeated at least three times.
Measurement of absorption and fluorescence spectra
Absorption spectrum (250-500 nm) of berberine and its derivatives (5e, 6e and 7e) were recorded on a UV-vis spectrophotometer (UV-1601, Shimadzu, Kyoto, Japan) with a quartz cuvette (path length 1 cm, accuracy ± 0.2 nm). Fluorescence emission spectrum were recorded on a fluorescence spectrophotometer (RF-5301PC, Shimadzu, Kyoto, Japan) with excitation at 420 nm and measure of emission from 450-700 nm (slit 3/3 nm) in a 1-cm quartz cuvette. A final concentration of berberine and its derivatives 5e, 6e and 7e were 10 μM diluted using methanol.
Appropriate blanks corresponding to the methanol were subtracted to correct the background.
Light source
The UVA light box consisting of eight UVA lamps (Blacklight blue, F8T5BLB, Sankyo Denki
Co. Ltd., Osaka, Japan) was custom made [33] . where E stands for visible light energy, t represents time expressed in second and, finally, P is lamp potency.
Photocytotoxic assay
The photocytotoxicity of berberine (1) and its derivatives (5e, 6e and 7e) was studied by using the MTT colorimetric assay with quantification of formazan formed by cleavage of the tetrazolium rings of MTT in DMSO by spectral measurement [29] . Various concentrations of the berberine (1) and berberine derivatives (5e, 6e and 7e) dissolved in 1% DMSO were added to the cells and incubation was continued for 4 h in the dark followed by photo-irradiation with visible light of 420 3.5.6. Intracellular uptake profiling of berberine and its derivatives in HepG2 cells
In order to establish a time profile for intracellular accumulation of these berberine derivatives, a HPLC analysis was carried out. The HepG2 cells treated with different berberine (1) and its derivatives (5e, 6e and 7e) were allowed to grow in 5 mL liquid culture. The cultures were incubated in a shaking incubator in the dark. After 0 h, 0.25 h, 1 h, 2 h, 4h, and 8 h, aliquots of cells were harvested by centrifuging at 6000 rpm for 5 min. The supernatant liquid was discarded and the cell pellet was washed thrice with 1 mL of 2×PBS in order to remove the uninternalized berberine and its derivatives. After this, the cells were gently resuspended in 0.2 mL methanol and then were filtered with a 0.22 μm filter into HPLC analysis. The HPLC analysis was carried out by exciting the sample at 350 nm and emission at 530 nm.
Cell morphological assessment
To detect morphological evidence of apoptosis, cells were visualized following DNA staining with the fluorescent dye Hoechst 33258 [30] . The HepG2 cells were plated in 6-cm dish at a density of 7×10 5 cells/well and were incubated overnight. The cells were treated with 0.5 μM concentrations berberine (1), compounds 5e, 6e and 7e for 4 h in the dark and treated with visible light (420 nm) for 10 min. Additionally, the HepG2 cells of compound 7e treatment were stained with 10 μM Hoechst 33258 (Sigma-Aldrich, St. Louis, MO, USA). After Cells were incubated in a dark room for 5 min, the cells were washed with PBS and then were observed by a fluorescent microscope (Zeiss, Axio Observer A1, Japan).
Cell cycle distribution analysis
Flow cytometry was used to obtain the cell cycle distribution and the apoptotic rate [31] . The 3.5.9. Measurement of intracellular singlet oxygen production Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 9 January 2020 doi:10.20944/preprints202001.0081.v1
Intracellular oxidant stress was monitored by measuring changes in fluorescence resulting from intracellular probe oxidation. Intracellular production of ROS, namely singlet oxygen ( 1 O2), was measured using DCFH-DA (Molecular Probes, USA) probe, respectively [32] . The level of intracellular singlet oxygen was detected using fluorescent dye DCF sensitivity. Briefly, the HepG2 (4×10 4 cells/ml) cells were pretreated with 0.5 μM of berberine (1) and 0.25 μM of its derivative (5e, 6e and 7e) for 2 h. At the end of the incubation, the drug-containing medium was removed, and the cells was washed with fresh medium and irradiated for 10 min with visible light (420 nm). After the incubation period for 24 h, intracellular peroxide level was detected by DCFH-DA as an intracellular fluorescence probe. After incubation with 20 μM DCFH-DA for 1 h, the cells were harvested and washed with PBS twice. A flow cytometer (Becton Dickinson, San Jose, CA, USA) was used to detect dichlorofluorescein (DCF). Data were collected and analyzed by ModFit 3.0 software (Verity Software House, ME, USA).
Measurement of the mitochondrial membrane potential
The changes of the mitochondrial membrane potential (MMP) were determined by using the fluorescent probe rhodamine 123 (Sigma, St Louis, USA). The dye Rh123 selectively enters mitochondria without influencing the membrane potential and are retains inside the mitochondria [33] . Once the MMP is lost, rhodamine 123 is subsequently washed out of the cells, leading to the decline of the fluorescence signal. HepG2 cells (1×10 5 cells/mL) were incubated with concentrations of 0.5 μM berberine (1) and 0.25 μM of its derivative (5e, 6e and 7e) for 2 h. At the end of the incubation, the drug-containing medium was removed, and the cells was washed with fresh medium and irradiated for 10 min with visible light (420 nm) for 24 h. Then stained with 2 mg/mL of rhodamine 123 for 20 min under gentle shaking. After washing with PBS, cells were immediately analyzed by flow cytometer (Becton Dickinson, San Jose, CA, USA) and data was analyzed using the ModFit 3.0 software (Verity Software House, ME, USA).
Statistical analysis
The values shown are mean ± SD of three independent experiments. Data are statistically evaluated by Student's t-test of SigmaPlot 11.0 and shown significantly different in *p < 0.05, **p < 0.01, and ***p < 0.001.
Conclusions
In summary, berberine was mortified with n-alkyl groups of different chain length and studied for their photo-induced cytotoxicity against three human cancer cell lines. Out of fifteen synthesized derivatives, we found three; compounds 5e, 6e and 7e, work the best in vitro, against the cancer cell lines. The increasing chain length of n-alkyl groups enhanced lipophilicity and the cellular permeability of the derivatives. Besides, its derivatives, compounds 5e, 6e and 7e had exhibited low dark toxicity and higher photocytotoxicity toward the cancer cell lines under tested. Thus derivatives 5e, 6e and 7e with a dodecyl group on the 9-, 13-or 13-O-position of berberine, respectively, showed high cellular uptake, photo-induced cytotoxicity in vitro, ROS generation, and induced cell apoptosis after 420 nm visible light irradiation. In the cell cycle distribution and apoptotic analysis, compound 5e, 6e or 7e induced S phase arrested and apoptosis in HepG2 cells after visible light irradiation. In Hoechst 33258 staining analysis, these three compounds markedly induce apoptosis, which were further confirmed by the positive rate of annexin V-FITC/PI double staining. Taken together, the presented results showed that compounds 5e, 6e and 7e increased cellular accumulation and enhanced the anticancer activity by photo-induced therapy against the cancer cells. We thus believe they could be novel anticancer drugs candidates.
